Ex Parte Perbost - Page 4


              Appeal No. 2004-1770                                                               Page 4                
              Application No. 09/895,050                                                                               

                     fluid present).  A “solid activator” is one which is solid at the operating                       
                     temperature at which it is used (normally at around a typical room                                
                     temperature[], such as between 10°C to 30°C).                                                     
              Pages 8-9.                                                                                               
                     “In the case of phosphoramidites, suitable activators are known and include                       
              tetrazole. . . .  In the case of phosphoramidites a non-protic low boiling point solvent                 
              could be used, for example, acetonitrile, dioxane, toluene,” etc.  Page 15.                              
                                                     Discussion                                                        
                     Claim 29 is directed to an apparatus for carrying out the disclosed method of                     
              making a biopolymer array.  The claimed apparatus comprises a deposition system that                     
              can separately dispense fluid compositions of biomonomers and a fluid composition of a                   
              solid activator, in combination with a processor to operate the deposition system; “the                  
              processor derives from the target array pattern a target drive pattern . . . [which                      
              comprises] instructions to the deposition system to perform the following at each of                     
              multiple regions at which a biomonomer is to be deposited:                                               
                     (i)  deposit the fluid composition of solid activator separate from and preceding                 
                        deposition of the biomonomer;                                                                  
                     (ii)  allow sufficient time for evaporation to leave solid activator at the region; and           
                     (iii) then deposit the biomonomer.”                                                               
                     The examiner rejected the claims as obvious in view of Baldeschwieler and                         
              Herschbein.  As the examiner noted, Baldeschwieler discloses an apparatus meeting                        
              most of the limitations of claim 29.  The disclosed apparatus that separately dispense                   
              fluid compositions of different biomonomers (e.g., phosphoramidite-derivatized                           
              nucleotides, see page 13, lines 3-10 and 10-21) and is also capable of dispensing a                      







Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007